ARTICLE SUMMARY:
A panel of medtech leaders opines on the current state of coding, coverage, and payment; Trump’s FDA retreats from the standards development process; a side-by-side comparison of device supply chain reporting rules in the US and EU; CMS' draft guidance on real-world evidence study protocols; and in Consultants’ Corner, expert tips on the new EU pathway for orphan devices.
